Cardlytics Q2 2024 Adj. EPS $(0.15) Misses $(0.13) Estimate, Sales $69.636M Miss $75.367M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cardlytics (NASDAQ:CDLX) reported Q2 2024 adjusted EPS of $(0.15), missing the $(0.13) estimate. Sales were $69.636M, below the $75.367M estimate and down 9.21% from last year.

August 07, 2024 | 9:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cardlytics reported Q2 2024 adjusted EPS of $(0.15), missing the $(0.13) estimate. Sales were $69.636M, below the $75.367M estimate and down 9.21% from last year.
Cardlytics' Q2 2024 earnings and sales both missed analyst estimates, and sales decreased year-over-year. This negative performance is likely to impact the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100